Gene: BRINP3
Official Full Name: BMP/retinoic acid inducible neural specific 3provided by HGNC
Gene Summary: This gene is overexpressed in pituitary tumors but is underexpressed in tongue squamous cell carcinomas, ulcerative colitis, and peri-implantitis. Polymorphisms that increase expression of this gene have been shown to increase vascular inflammation, and an association of this gene with myocardial infarction has been demonstrated. Finally, hypermethylation of this gene may find usefulness as a biomarker for gastric cancer. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA03097 | BRINP3 Knockout cell line (AC16) | Human | BRINP3 | 1:3-1:4 | negative | Online Inquiry |
| KOA18544 | BRINP3 Knockout cell line (BEAS-2B) | Human | BRINP3 | 1:3~1:4 | negative | Online Inquiry |
| KOA33994 | BRINP3 Knockout cell line (U-2932) | Human | BRINP3 | 1:2-1:4 | negative | Online Inquiry |
| KOA49401 | BRINP3 Knockout cell line (TPC-1) | Human | BRINP3 | 1:5-1:8 | negative | Online Inquiry |
| KOA64802 | BRINP3 Knockout cell line (NCM460) | Human | BRINP3 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.